Correspondence 0000950170-23-033011 from Aptevo Therapeutics Inc. (APVO)
Aptevo Therapeutics Inc.
Date: July 14, 2023 · CIK: 0001671584 · Accession: 0000950170-23-033011
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273067
Letter
A.G.P. / Alliance Global Partners
590 Madison Ave., 28th Floor
New York, NY 10022
July 14, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
Aptevo Therapeutics Inc.
Registration Statement on Form S-1
File No. 333-273067
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P / Alliance Global Partners, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:30pm Eastern Time on July 18, 2023 or as soon thereafter as practicable.
Very truly yours,
A.G.P / Alliance Global Partners
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
A.G.P. / Alliance Global Partners
590 Madison Ave., 28th Floor
New York, NY 10022
July 14, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
Aptevo Therapeutics Inc.
Registration Statement on Form S-1
File No. 333-273067
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), A.G.P / Alliance Global Partners, as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:30pm Eastern Time on July 18, 2023 or as soon thereafter as practicable.
Very truly yours,
A.G.P / Alliance Global Partners
By:
/s/ Thomas J. Higgins
Name:
Thomas J. Higgins
Title:
Managing Director